Levels of spinorphin in cerebrospinal fluid derived from patients with pain increase with decreasing dipeptidyl peptidase III

[1]  Go-Shine Huang,et al.  Loss of intrathecal morphine analgesia in terminal cancer patients is associated with high levels of excitatory amino acids in the CSF , 2002, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[2]  P. Murphy,et al.  The Endogenous Opioid Spinorphin Blocks fMet-Leu-Phe-Induced Neutrophil Chemotaxis by Acting as a Specific Antagonist at the N-Formylpeptide Receptor Subtype FPR , 2001, The Journal of Immunology.

[3]  A. Laat,et al.  Tactile threshold and pressure pain threshold during treatment of orofacial pain: an explorative study , 2001, Clinical Oral Investigations.

[4]  Xiao-jun Xu,et al.  Increased level of cholecystokinin in cerebrospinal fluid is associated with chronic pain-like behavior in spinally injured rats , 2001, Peptides.

[5]  Y. Yamamoto,et al.  Effects of spinorphin and tynorphin on synaptic transmission in rat hippocampal slices. , 2001, European journal of pharmacology.

[6]  N. Shimetani,et al.  Levels of three inflammation markers, C-reactive protein, serum amyloid A protein and procalcitonin, in the serum and cerebrospinal fluid of patients with meningitis. , 2001, Scandinavian journal of clinical and laboratory investigation.

[7]  H. Ueda,et al.  Complete inhibition of purinoceptor agonist-induced nociception by spinorphin, but not by morphine , 2000, Peptides.

[8]  Y. Yamamoto,et al.  Identification of dipeptidyl peptidase III in human neutrophils. , 2000, Biochemical and biophysical research communications.

[9]  K. Burhop,et al.  Structural Requirements and Mechanism of the Pressor Activity of Leu-Val-Val-hemorphin-7, a Fragment of Hemoglobin β-chain in Rats , 1998, Peptides.

[10]  V. Ivanov,et al.  LVV‐ and VV‐hemorphins: comparative levels in rat tissues , 1998, FEBS letters.

[11]  Y. Yamamoto,et al.  Inhibitory action of spinorphin, an endogenous regulator of enkephalin-degrading enzymes, on carrageenan-induced polymorphonuclear neutrophil accumulation in mouse air-pouches. , 1998, Life sciences.

[12]  Y. Yamamoto,et al.  Inhibitory effects of spinorphin, a novel endogenous regulator, on chemotaxis, O2- generation, and exocytosis by N-formylmethionyl-leucyl-phenylalanine (FMLP)-stimulated neutrophils. , 1997, Biochemical pharmacology.

[13]  G. Smythe,et al.  Mass Spectrometric Identification and Quantification of Hemorphins Extracted from Human Adrenal and Pheochromocytoma Tissue , 1997, Journal of neurochemistry.

[14]  J. Piot,et al.  Opioid peptides derived from hemoglobin: hemorphins. , 1997, Biopolymers.

[15]  F. Nyberg,et al.  The hemorphins: a new class of opioid peptides derived from the blood protein hemoglobin. , 1997, Biopolymers.

[16]  F. Nyberg,et al.  Concomitant increase in blood plasma levels of immunoreactive hemorphin-7 and β-endorphin following long distance running , 1993, Regulatory Peptides.

[17]  T. Hazato,et al.  [Study of a new endogenous inhibitor of enkephalin-degrading enzymes; pharmacological function and metabolism of spinorphin]. , 1993, Masui. The Japanese journal of anesthesiology.

[18]  S. Turcaud,et al.  Inhibition of the enkephalin-metabolizing enzymes by the first systemically active mixed inhibitor prodrug RB 101 induces potent analgesic responses in mice and rats. , 1992, The Journal of pharmacology and experimental therapeutics.

[19]  D. Morris,et al.  Stereoselective effect of morphine on antinociception and endogenous opioid peptide levels in plasma but not cerebrospinal fluid of dogs. , 1991, Life sciences.